Market Cap 327.88B
Revenue (ttm) 56.33B
Net Income (ttm) 4.28B
EPS (ttm) N/A
PE Ratio 17.83
Forward PE 14.91
Profit Margin 7.59%
Debt to Equity Ratio 47.80
Volume 11,609,000
Avg Vol 8,505,284
Day's Range N/A - N/A
Shares Out 1.77B
Stochastic %K 90%
Beta 0.56
Analysts Strong Sell
Price Target $209.68

Latest News on ABBV

Final Trades: JPMorgan, Meta, Abbvie and Gap

May 30, 2025, 4:20 PM EDT - 1 day ago

Final Trades: JPMorgan, Meta, Abbvie and Gap

META GAP JPM


AbbVie Partners with Chicago Cubs on "Striking Out Cancer"

May 30, 2025, 8:00 AM EDT - 1 day ago

AbbVie Partners with Chicago Cubs on "Striking Out Cancer"


Best Dividend Aristocrats For June 2025

May 27, 2025, 10:15 PM EDT - 4 days ago

Best Dividend Aristocrats For June 2025

ABT ADM ADP AFL ALB AMCR AOS


3 Stocks That Will Profit From Trump's Drug Price Cut

May 16, 2025, 1:08 PM EDT - 15 days ago

3 Stocks That Will Profit From Trump's Drug Price Cut

LLY NVO


Is It Time To Buy AbbVie Stock At $180?

May 16, 2025, 8:30 AM EDT - 15 days ago

Is It Time To Buy AbbVie Stock At $180?


US FDA approves AbbVie's drug for a type of lung cancer

May 14, 2025, 1:23 PM EDT - 17 days ago

US FDA approves AbbVie's drug for a type of lung cancer


Best Dividend Aristocrats For May 2025

Apr 29, 2025, 8:07 PM EDT - 4 weeks ago

Best Dividend Aristocrats For May 2025

ABT ADM ADP AFL ALB AMCR AOS


Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results

Apr 27, 2025, 11:40 PM EDT - 4 weeks ago

Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results


AbbVie's First Quarter Beat And Raise Leaves Room For More

Apr 25, 2025, 5:17 PM EDT - 5 weeks ago

AbbVie's First Quarter Beat And Raise Leaves Room For More


AbbVie: Q1 Earnings Reinforce Positive Momentum

Apr 25, 2025, 4:00 PM EDT - 5 weeks ago

AbbVie: Q1 Earnings Reinforce Positive Momentum